0001520138-26-000499.txt : 20261119
0001520138-26-000499.hdr.sgml : 20261119
20261118175925
ACCESSION NUMBER: 0001520138-26-000499
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20261119
DATE AS OF CHANGE: 20261118
EFFECTIVENESS DATE: 20261119
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOVIE INC.
CENTRAL INDEX KEY: 0001580149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
EIN: 462510769
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-605260
FILM NUMBER: 261571755
BUSINESS ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
BUSINESS PHONE: 775-888-3162
MAIL ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
FORMER COMPANY:
FORMER CONFORMED NAME: NANOANTIBIOTICS, INC.
DATE OF NAME CHANGE: 20130625
D
1
primary_doc.xml
X0708
D
LIVE
0001580149
BIOVIE INC.
680 W. NYE LANE, SUITE 201
CARSON CITY
NV
NEVADA
89703
775-888-3162
NEVADA
None
NANOANTIBIOTICS, INC.
Corporation
true
Cuong
Do
c/o BioVie Inc.
680 W NYE LANE, SUITE 201
CARSON CITY
NV
NEVADA
89703
Executive Officer
President and CEO
Joanne
Wendy
Kim
c/o BioVie Inc.
680 W NYE LANE, SUITE 201
Carson City
NV
NEVADA
89703
Executive Officer
CFO
Sigmund
Rogich
c/o BioVie Inc.
680 W NYE LANE, SUITE 201
Carson City
NV
NEVADA
89703
Director
Michael
Sherman
c/o BioVie Inc.
680 W NYE LANE, SUITE 201
Carson City
NV
NEVADA
89703
Director
Kameel
Farag
c/o BioVie Inc.
680 W NYE LANE, SUITE 201
Carson City
NV
NEVADA
89703
Director
Amy
Chappell
c/o BioVie Inc.
680 W NYE LANE, SUITE 201
Carson City
NV
NEVADA
89703
Director
Jim
Lang
c/o BioVie Inc.
680 W NYE LANE, SUITE 201
Carson City
NV
NEVADA
89703
Director
Biotechnology
Decline to Disclose
- 06b
false
2026-11-03
false
true
true
false
0
0
0
0
The warrants were issued without additional consideration in connection with a registered offering of common stock at $1.60 per share and accompanying warrant. No separate consideration was paid.
false
1
0
0
0
false
BIOVIE INC.
/s/ Joanne Wendy Kim
Joanne Wendy Kim
CFO
2026-11-18